Form 4 for HAE HAEMONETICS CORP
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-06 · accession 0001127602-24-018160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-06 | HAE | Simon, Christopher | Pres, CEO, Dir | F - Tax | $87.38 | -71.3K | 362.5K | -16% | -$6.23M |
| D | 2024-06-07 | 2024-06-06 | HAE | Simon, Christopher | Pres, CEO, Dir | M - OptEx | $41.64 | +104.5K | 433.9K | +32% | +$4.35M |
| D | 2024-06-07 | 2024-06-06 | HAE | Simon, Christopher | Pres, CEO, Dir | M - OptEx | $0.00 | -104.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-06 | F | D | 71,335 | $87.38 | 362,542 | D | — | — | (F3) Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I. (F2) This number includes unvested restricted stock units previously reported. |
| 2 | Common | Common Stock | 2024-06-06 | M | A | 104,516 | $41.64 | 433,877 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-06-06 | M | D | 104,516 | $0.00 | 0 | D | $41.64 · 2018-06-06 to 2024-06-06 | 104,516 Common Stock | (F4) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |